⌘K

Home/Filings/4/0001062993-22-001688

4//SEC Filing

Borges Luis 4

Accession 0001062993-22-001688

CIK 0001850119other

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:50 PM ET

Size

5.2 KB

Accession

0001062993-22-001688

Insider Transaction Report

Form 4

Period: 2022-01-25

Century Therapeutics, Inc.IPSC

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2022-01-25+105,000→ 105,000 total
Exercise: $13.15Exp: 2032-01-25→ Common Stock (105,000 underlying)

Footnotes (1)

[F1]The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Century Therapeutics, Inc.

CIK 0001850119

Entity typeother

Related Parties

1

filerCIK 0001684015

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 4:50 PM ET
Size: 5.2 KB

View on SEC.gov